Helius Medical Technologies, Inc. (HSDT)
NASDAQ: HSDT · IEX Real-Time Price · USD
5.20
-0.65 (-11.11%)
Apr 16, 2024, 10:30 AM EDT - Market open

HSDT Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201520142013
Net Income
-8.85-14.07-18.13-14.13-9.78-28.62-28.02-6.88-9.84-1.07
Depreciation & Amortization
0.210.310.370.710.190.060.02000
Share-Based Compensation
1.632.294.272.534.698.11.821.232.340.81
Other Operating Activities
-3.41-2.830.1-0.84-16.10.856.86-2.291.18-0.09
Operating Cash Flow
-10.42-14.31-13.39-11.74-21-19.62-19.33-7.94-6.32-0.35
Capital Expenditures
-0.03-0.01-0.06-0.01-0.35-0.44-0.19000
Acquisitions
0000-0.4200000
Change in Investments
00000000.38-0.380
Investing Cash Flow
-0.03-0.01-0.06-0.01-0.77-0.44-0.190.38-0.380
Share Issuance / Repurchase
1.1418.6424.0210.651.943.1923.477.836.680
Debt Issued / Paid
000000020.780.36
Other Financing Activities
-0.07-0.78-2.89-1.02-0.25-3.16-1.25-0.140.02-
Financing Cash Flow
1.0817.8721.139.641.6540.0322.229.697.480.36
Exchange Rate Effect
0-0-0.01-0.02-0.010.050.190.09-0.380
Net Cash Flow
-9.373.547.67-2.13-20.1220.022.892.230.40.02
Free Cash Flow
-10.45-14.32-13.44-11.75-21.35-20.06-19.52-7.94-6.32-0.35
Free Cash Flow Margin
-1621.89%-1819.70%-2575.48%-1777.16%-1427.27%-4196.86%----
Free Cash Flow Per Share
-17.18-53.05-273.61-490.37-1417.92-1540.70-1832.86-1044.04-969.55-95.14
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).